Skip to main content

Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria

Deliverables

Establish transgenic P. knowlesi GIA assay methodology and assess blood-stage clinical trial samples

Establish transgenic P. knowlesi GIA assay methodology and assess blood-stage clinical trial samples

Generation and fitness assessment of transgenic parasite Pf-Pvs25

Generation and fitness assessment of transgenic parasite Pf-Pvs25 to develop SMFA assay

Searching for OpenAIRE data...

Publications

Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody

Author(s): Thomas. A. Rawlinson, Natalie M. Barber, Franziska Mohring, Jee Sun Cho, Varakorn Kosaisavee, Samuel F. Gérard, Daniel G. W. Alanine, Geneviève M. Labbé, Sean C. Elias, Sarah E. Silk, Doris Quinkert, Jing Jin, Jennifer M. Marshall, Ruth O. Payne, Angela M. Minassian, Bruce Russell, Laurent Rénia, François H. Nosten, Robert W. Moon, Matthew K. Higgins, Simon J. Draper
Published in: Nature Microbiology, Issue 4/9, 2019, Page(s) 1497-1507, ISSN 2058-5276
DOI: 10.1038/s41564-019-0462-1